Cargando…

Therapeutic Benefits of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome: Potential Mechanisms and Challenges

Acute respiratory distress syndrome (ARDS) presents as a form of acute respiratory failure resulting from non-cardiogenic pulmonary edema due to excessive alveolocapillary permeability, which may be pulmonary or systemic in origin. In the last 3 years, the coronavirus disease 2019 pandemic has resul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Chao, Zhang, Lin, Liu, Fuli, Shen, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473549/ https://www.ncbi.nlm.nih.gov/pubmed/36120184 http://dx.doi.org/10.2147/JIR.S372046

Ejemplares similares

Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment
por: Wang, Wendi, et al.
Publicado: (2021)

Mesenchymal stem cell use in acute respiratory distress syndrome: a potential therapeutic application
por: Freitag, Julien, et al.
Publicado: (2020)

Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome
por: Wang, Yan-Yang, et al.
Publicado: (2013)

Mesenchymal Stem Cells Represent a Potential Therapeutic Option for Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome
por: Zhao, Xuan, et al.
Publicado: (2020)

Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome
por: Harrell, Carl Randall, et al.
Publicado: (2020)

RUNX1 mediates the therapeutic effects of mesenchymal stem cells‐derived microparticles in acute respiratory distress syndrome
por: Predescu, Dan, et al.
Publicado: (2023)

Mesenchymal stem cells - a promising therapy for Acute Respiratory Distress Syndrome
por: Hayes, Mairead, et al.
Publicado: (2012)

Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome
por: Han, Jibin, et al.
Publicado: (2019)

Mesenchymal Stem Cells Reconditioned in Their Own Serum Exhibit Augmented Therapeutic Properties in the Setting of Acute Respiratory Distress Syndrome
por: Xu, Amy L., et al.
Publicado: (2019)

Immunomodulatory Mechanisms and Therapeutic Potential of Mesenchymal Stem Cells
por: Yang, Guoqiang, et al.
Publicado: (2023)

An overview of mesenchymal stem cells and their potential therapeutic benefits in cancer therapy
por: Lim, Shern Kwok, et al.
Publicado: (2021)

Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome
por: Horie, Shahd, et al.
Publicado: (2016)

The effect of acute respiratory distress syndrome on bone marrow-derived mesenchymal stem cells
por: Antebi, Ben, et al.
Publicado: (2018)

Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics
por: Qin, Hua, et al.
Publicado: (2020)

Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome
por: Han, Jibin, et al.
Publicado: (2019)

Mesenchymal stem cell‐derived extracellular vesicles for the treatment of acute respiratory distress syndrome
por: Abraham, Aswin, et al.
Publicado: (2019)

Mesenchymal Stem Cell: Does it Work in an Experimental Model with Acute Respiratory Distress Syndrome?
por: Yilmaz, Sema, et al.
Publicado: (2012)

Mesenchymal Stem Cell–derived Exosomes: Are They Another Therapeutic Method for Extracorporeal Membrane Oxygenation–supported Acute Respiratory Distress Syndrome?
por: Zhang, Lanyu, et al.
Publicado: (2020)

Overexpression of FoxM1 optimizes the therapeutic effect of bone marrow mesenchymal stem cells on acute respiratory distress syndrome
por: Luo, Yuling, et al.
Publicado: (2023)

Extracellular Vesicles Derived from Mesenchymal Stem Cells: A Potential Biodrug for Acute Respiratory Distress Syndrome Treatment
por: Sun, Hao, et al.
Publicado: (2022)

Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome
por: Tovar, Isabel, et al.
Publicado: (2020)

Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management
por: Aslan, Anolin, et al.
Publicado: (2021)

Identification of potential biomarkers and therapeutic targets for posttraumatic acute respiratory distress syndrome
por: Qi, Peng, et al.
Publicado: (2023)

Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases
por: Rolandsson Enes, Sara, et al.
Publicado: (2021)

Acute Respiratory Distress Syndrome: Challenge for Diagnosis and Therapy
por: Pan, Chun, et al.
Publicado: (2018)

Glucocorticoid Treatment in Acute Respiratory Distress Syndrome: An Overview on Mechanistic Insights and Clinical Benefit
por: Zhang, Jinquan, et al.
Publicado: (2023)

Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19
por: Iglesias, Martin, et al.
Publicado: (2021)

Acute Respiratory Distress Syndrome: Pathophysiology and Therapeutic Options
por: Pierrakos, Charalampos, et al.
Publicado: (2012)

RNAi therapeutic strategies for acute respiratory distress syndrome
por: Jagrosse, Melissa L., et al.
Publicado: (2019)

Mechanical ventilation of acute respiratory distress syndrome
por: Ochiai, Ryoichi
Publicado: (2015)

Mesenchymal stem cells with downregulated Hippo signaling attenuate lung injury in mice with lipopolysaccharide-induced acute respiratory distress syndrome
por: Li, Lang, et al.
Publicado: (2019)

Reply to Zhang and Hei: Mesenchymal Stem Cell–derived Exosomes: Are They Another Therapeutic Method for Extracorporeal Membrane Oxygenation–supported Acute Respiratory Distress Syndrome?
por: Millar, Jonathan E., et al.
Publicado: (2020)

Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome
por: Lin, Feng, et al.
Publicado: (2020)

Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Supported with Extracorporeal Membrane Oxygenation. Lost in Translational Research?
por: Del Sorbo, Lorenzo, et al.
Publicado: (2020)

Increased mobilization of mesenchymal stem cells in patients with acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation
por: Patry, Christian, et al.
Publicado: (2020)

Current status and prospects of basic research and clinical application of mesenchymal stem cells in acute respiratory distress syndrome
por: Liang, Tian-Yu, et al.
Publicado: (2023)

Treatment of Acute Respiratory Distress Syndrome Caused by COVID-19 with Human Umbilical Cord Mesenchymal Stem Cells
por: Bukreieva, Tetiana, et al.
Publicado: (2023)

Therapeutic Potential of Wharton’s Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges
por: Kamal, Mohamed M., et al.
Publicado: (2020)

Mesenchymal stem cells-derived extracellular vesicles in acute respiratory distress syndrome: a review of current literature and potential future treatment options
por: Shah, Trushil G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ddl05pops1edu39ov0bvu72cir